Author:
Zimpfer A.,Glass Ä.,Zettl H.,Maruschke M.,Hakenberg O. W.,Erbersdobler A.
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Albiges L, Guegan J, Le Formal A et al (2014) MET is a potential target across all papillary renal cell carcinomas: Result from a large molecular study of pRCC with CGH array and matching gene expression array. Clin Cancer Res 20:3411–3421
2. Chen F, Zhang Y, Şenbabaoğlu Y et al (2016) Multilevel genomics-based taxonomy of renal cell carcinoma. Cell Rep 14:2476–2489
3. Choueiri TK, Motzer RJ (2017) Systemic therapy for metastatic renal-cell carcinoma. N Engl J Med 376:354–366
4. Choueiri TK, Plimack E, Arkenau H‑T et al (2017) Biomarker-based phase II trial of savolitinib in patients with advanced papillary renal cancer. J Clin Oncol 35:2993–3001
5. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (Hrsg) (2004) World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献